{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:17:23Z","timestamp":1789406243234,"version":"build-2803163510"},"reference-count":131,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,2,28]]},"abstract":"<jats:p>The post-translational modification protein S-acylation (commonly known as palmitoylation) plays a critical role in regulating a wide range of biological processes including cell growth, cardiac contractility, synaptic plasticity, endocytosis, vesicle trafficking, membrane transport and biased-receptor signalling. As a consequence, zDHHC-protein acyl transferases (zDHHC-PATs), enzymes that catalyse the addition of fatty acid groups to specific cysteine residues on target proteins, and acyl proteins thioesterases, proteins that hydrolyse thioester linkages, are important pharmaceutical targets. At present, no therapeutic drugs have been developed that act by changing the palmitoylation status of specific target proteins. Here, we consider the role that palmitoylation plays in the development of diseases such as cancer and detail possible strategies for selectively manipulating the palmitoylation status of specific target proteins, a necessary first step towards developing clinically useful molecules for the treatment of disease.<\/jats:p>","DOI":"10.1042\/bst20190707","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T19:21:23Z","timestamp":1579548083000},"page":"281-290","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutic targeting of protein S-acylation for the treatment of disease"],"prefix":"10.1042","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7349-5647","authenticated-orcid":false,"given":"Niall J.","family":"Fraser","sequence":"first","affiliation":[{"name":"School of Medicine, University of Dundee, Dundee, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Howie","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof J.","family":"Wypijewski","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-4433","authenticated-orcid":false,"given":"William","family":"Fuller","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2019,12,24]]},"reference":[{"key":"2021111915573589700_BST-2019-0707CC1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1194\/jlr.R600007-JLR200","article-title":"Protein palmitoylation by a family of DHHC protein S-acyltransferases","volume":"47","year":"2006","journal-title":"J. Lipid Res."},{"key":"2021111915573589700_BST-2019-0707CC2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrm2084","article-title":"Palmitoylation: policing protein stability and traffic","volume":"8","year":"2007","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"2021111915573589700_BST-2019-0707CC3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1152\/physrev.00032.2014","article-title":"The physiology of protein-S-acylation","volume":"95","year":"2015","journal-title":"Physiol. Rev."},{"key":"2021111915573589700_BST-2019-0707CC4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/tra.12510","article-title":"The role of S-acylation in protein trafficking","volume":"18","year":"2017","journal-title":"Traffic"},{"key":"2021111915573589700_BST-2019-0707CC5","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1126\/science.1105654","article-title":"An acylation cycle regulates localization and activity of palmitoylated Ras isoforms","volume":"307","year":"2005","journal-title":"Science"},{"key":"2021111915573589700_BST-2019-0707CC6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BST20140235","article-title":"Enzymatic protein depalmitoylation by acyl protein thioesterases","volume":"43","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"2021111915573589700_BST-2019-0707CC7","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1073\/pnas.91.7.2800","article-title":"Receptor regulation of G-protein palmitoylation","volume":"91","year":"1994","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC8","doi-asserted-by":"publisher","first-page":"21006","DOI":"10.1073\/pnas.0806700106","article-title":"Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels","volume":"105","year":"2008","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1096\/fj.08-114637","article-title":"Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts","volume":"23","year":"2009","journal-title":"FASEB J."},{"key":"2021111915573589700_BST-2019-0707CC10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuron.2009.08.017","article-title":"Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking","volume":"64","year":"2009","journal-title":"Neuron"},{"key":"2021111915573589700_BST-2019-0707CC11","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1038\/ncomms12035","article-title":"Cardiac sodium channel palmitoylation regulates channel availability and myocyte excitability with implications for arrhythmia generation","volume":"7","year":"2016","journal-title":"Nat. Commun."},{"key":"2021111915573589700_BST-2019-0707CC12","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1074\/jbc.M117.776146","article-title":"Specific palmitoyltransferases associate with and activate the epithelial sodium channel","volume":"292","year":"2017","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1085\/jgp.201411176","article-title":"Ion channel regulation by protein S-acylation","volume":"143","year":"2014","journal-title":"J. Gen. Physiol."},{"key":"2021111915573589700_BST-2019-0707CC14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.108.193011","article-title":"Palmitoylation of ATP-Binding Cassette transporter A1 is essential for its trafficking and function","volume":"105","year":"2009","journal-title":"Circ. Res."},{"key":"2021111915573589700_BST-2019-0707CC15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"2021111915573589700_BST-2019-0707CC16","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1074\/jbc.M110.187872","article-title":"Palmitoylation controls dopamine transporter kinetics, degradation and protein kinase C-dependent regulation","volume":"286","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC17","doi-asserted-by":"publisher","first-page":"36020","DOI":"10.1074\/jbc.M111.282145","article-title":"The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation","volume":"286","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC18","doi-asserted-by":"publisher","first-page":"17534","DOI":"10.1073\/pnas.1413627111","article-title":"Substrate recognition by the cell surface palmitoyl transferase DHHC5","volume":"111","year":"2014","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC19","doi-asserted-by":"publisher","first-page":"re14","DOI":"10.1126\/stke.3592006re14","article-title":"Palmitoylation of ligands, receptors and intracellular signaling molecules","volume":"2006","year":"2006","journal-title":"Sci. STKE"},{"key":"2021111915573589700_BST-2019-0707CC20","doi-asserted-by":"publisher","first-page":"e28018","DOI":"10.1371\/journal.pone.0028018","article-title":"The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2","volume":"6","year":"2011","journal-title":"PLOS One"},{"key":"2021111915573589700_BST-2019-0707CC21","doi-asserted-by":"publisher","first-page":"19014","DOI":"10.1074\/jbc.M110.189977","article-title":"Differential regulation of two palmitoylation sites in the cytoplasmic tail of the (1-adrenergic receptor","volume":"286","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC22","doi-asserted-by":"publisher","first-page":"e140661","DOI":"10.1371\/journal.pone.0140661","article-title":"Effect of C-Terminal S-palmitoylation on D2 dopamine receptor trafficking and stability","volume":"10","year":"2015","journal-title":"PLOS One"},{"key":"2021111915573589700_BST-2019-0707CC23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molcel.2016.04.003","article-title":"Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling","volume":"62","year":"2016","journal-title":"Mol. Cell"},{"key":"2021111915573589700_BST-2019-0707CC24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07605","article-title":"Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation","volume":"456","year":"2008","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1083\/jcb.126.2.353","article-title":"Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae","volume":"126","year":"1994","journal-title":"J. Cell Biol."},{"key":"2021111915573589700_BST-2019-0707CC26","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1073\/pnas.1509929112","article-title":"Rapid and transient palmitoylation of the tyrosine kinase Lck mediates Fas signalling","volume":"112","year":"2015","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","article-title":"Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization","volume":"179","year":"2019","journal-title":"Cell"},{"key":"2021111915573589700_BST-2019-0707CC28","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.1074\/jbc.M111.337246","article-title":"DHHC protein S-acyltransferases use similar ping-pong kinetic mechanisms but display different acyl-CoA specificities","volume":"287","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bbalip.2006.03.010","article-title":"Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins","volume":"1761","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111915573589700_BST-2019-0707CC30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1042\/BST20180429","article-title":"The molecular mechanism of DHHC protein acyltransferases","volume":"47","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"2021111915573589700_BST-2019-0707CC31","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1021\/cr200075y","article-title":"The metabolic serine hydrolases and their functions in mammalian physiology and disease","volume":"111","year":"2011","journal-title":"Chem. Rev."},{"key":"2021111915573589700_BST-2019-0707CC32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbalip.2013.01.002","article-title":"Mammalian alpha beta hydrolase domain (ABHD) proteins: lipid metabolizing enzymes at the interface of cell signaling and energy metabolism","volume":"1831","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111915573589700_BST-2019-0707CC33","doi-asserted-by":"publisher","first-page":"15830","DOI":"10.1074\/jbc.273.25.15830","article-title":"A cytoplasmic acyl-protein thioesterase that removes palmitate from G protein alpha subunits and p21(RAS)","volume":"273","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC34","doi-asserted-by":"publisher","first-page":"31740","DOI":"10.1074\/jbc.M202505200","article-title":"Characterization of Saccharomyces cerevisiae acyl-protein thioesterase 1, the enzyme responsible for G protein alpha subunit deacylation in vivo","volume":"277","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC35","doi-asserted-by":"publisher","first-page":"33148","DOI":"10.1074\/jbc.274.46.33148","article-title":"Depalmitoylation of endothelial nitric-oxide synathase by acyl-protein thioesterase 1 is potentiated by Ca2+-calmodulin","volume":"274","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC36","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1182\/blood-2006-11-055772","article-title":"SNAP-23 and syntaxin-2 localize to the extracellular surface of the platelet plasma membrane","volume":"110","year":"2007","journal-title":"Blood"},{"key":"2021111915573589700_BST-2019-0707CC37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1388-1981(99)00007-4","article-title":"Sequence, expression in Escherichia coli, and characterization of lysophospholipase II","volume":"1437","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111915573589700_BST-2019-0707CC38","doi-asserted-by":"publisher","first-page":"e11306","DOI":"10.7554\/eLife.11306","article-title":"ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization","volume":"4","year":"2015","journal-title":"eLife"},{"key":"2021111915573589700_BST-2019-0707CC39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbcan.2015.06.004","article-title":"Protein S-palmitoylation and cancer","volume":"1856","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111915573589700_BST-2019-0707CC40","doi-asserted-by":"publisher","first-page":"e46666","DOI":"10.15252\/embr.201846666","article-title":"Protein palmitoylation and cancer","volume":"19","year":"2018","journal-title":"EMBO Rep."},{"key":"2021111915573589700_BST-2019-0707CC41","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/1541-7786.MCR-14-0608","article-title":"Systematic siRNA screen unmasks NSCLC growth dependence by palmitoyltransferase DHHC5","volume":"13","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"2021111915573589700_BST-2019-0707CC42","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1158\/0008-5472.CAN-17-1139","article-title":"EZH2 palmitoylation mediated by ZDHHC5 in p53-mutant glioma drives malignant development and progression","volume":"77","year":"2017","journal-title":"Cancer Res."},{"key":"2021111915573589700_BST-2019-0707CC43","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1158\/0008-5472.CAN-17-1536","article-title":"Protein acyltransferase DHHC3 regulates breast tumor growth, oxidative stress and senescence","volume":"77","year":"2017","journal-title":"Cancer Res."},{"key":"2021111915573589700_BST-2019-0707CC44","doi-asserted-by":"publisher","first-page":"e8313","DOI":"10.15252\/emmm.201708313","article-title":"Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer","volume":"10","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"2021111915573589700_BST-2019-0707CC45","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1038\/jid.2015.314","article-title":"Increased susceptibility to skin carcinogenesis associated with a spontaneous mouse mutation in the palmitoyl transferase Zdhhc13 gene","volume":"135","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"2021111915573589700_BST-2019-0707CC46","doi-asserted-by":"publisher","first-page":"e22058","DOI":"10.7554\/eLife.22058","article-title":"Palmitoylated SCP1 is targeted to the plasma membrane and negatively regulates angiogenesis","volume":"6","year":"2017","journal-title":"eLife"},{"key":"2021111915573589700_BST-2019-0707CC47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2016.06.008","article-title":"Palmitoylation in Alzheimer's disease and other neurodegenerative diseases","volume":"111","year":"2016","journal-title":"Pharmacol. Res."},{"key":"2021111915573589700_BST-2019-0707CC48","doi-asserted-by":"publisher","first-page":"9665","DOI":"10.1073\/pnas.1708568114","article-title":"Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease","volume":"114","year":"2017","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","year":"2018","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC50","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"2021111915573589700_BST-2019-0707CC51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4161\/sgtp.1.1.12178","article-title":"Ras history: the saga continues","volume":"1","year":"2010","journal-title":"Small GTPases"},{"key":"2021111915573589700_BST-2019-0707CC52","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/369411a0","article-title":"Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane","volume":"369","year":"1994","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC53","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/j.1460-2075.1995.tb07316.x","article-title":"Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation","volume":"14","year":"1995","journal-title":"EMBO J."},{"key":"2021111915573589700_BST-2019-0707CC54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/370527a0","article-title":"Phosphatidylinositol-3-OH kinase as a direct target of Ras","volume":"370","year":"1994","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1098\/rstb.1996.0020","article-title":"Phosphatidylinositol 3\u2032kinase: one of the effectors of Ras","volume":"351","year":"1996","journal-title":"Philos. Trans. R. Soc. Lond. B"},{"key":"2021111915573589700_BST-2019-0707CC56","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","year":"2007","journal-title":"Cell"},{"key":"2021111915573589700_BST-2019-0707CC57","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","year":"2012","journal-title":"Cancer Res."},{"key":"2021111915573589700_BST-2019-0707CC58","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1242\/jcs.182873","article-title":"RAS isoforms and mutations in cancer at a glance","volume":"129","year":"2016","journal-title":"J. Cell Sci."},{"key":"2021111915573589700_BST-2019-0707CC59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrm3255","article-title":"Regulating the regulator: post-translational modification of RAS","volume":"13","year":"2012","journal-title":"Nature Rev. Mol. Cell. Biol."},{"key":"2021111915573589700_BST-2019-0707CC60","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/1078-0432.CCR-14-3214","article-title":"Targeting Ras membrane association: back to the future for anti-Ras drug discovery?","volume":"21","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"2021111915573589700_BST-2019-0707CC61","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0092-8674(89)90054-8","article-title":"All ras proteins are polyisoprenylated but only some are palmitoylated","volume":"57","year":"1989","journal-title":"Cell"},{"key":"2021111915573589700_BST-2019-0707CC62","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.1073\/pnas.86.21.8323","article-title":"P21ras is modified by a farnesyl isoprenoid","volume":"86","year":"1989","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC63","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/310583a0","article-title":"The p21 ras C-terminus is required for transformation and membrane association","volume":"310","year":"1984","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC64","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2174\/0929867013372021","article-title":"Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. The discovery and development of SCH 66336","volume":"8","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"2021111915573589700_BST-2019-0707CC65","first-page":"131","article-title":"Characterization of the anti-tumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro","volume":"61","year":"2001","journal-title":"Cancer Res."},{"key":"2021111915573589700_BST-2019-0707CC66","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/annonc\/mdf173","article-title":"A phase II trial of farnesyl protein transferase inhibitor SCH given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan","volume":"13","year":"2002","journal-title":"Ann. Oncol."},{"key":"2021111915573589700_BST-2019-0707CC67","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1200\/JCO.2004.10.112","article-title":"Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer","volume":"22","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"2021111915573589700_BST-2019-0707CC68","doi-asserted-by":"publisher","first-page":"14459","DOI":"10.1074\/jbc.272.22.14459","article-title":"K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors","volume":"272","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC69","doi-asserted-by":"publisher","first-page":"viii372","DOI":"10.1093\/annonc\/mdy287.002","article-title":"Preliminary results from a phase 2 trial of tipifarnib in Squamous Cell Carcinomas (SCCs) with HRAS mutations","volume":"29","year":"2018","journal-title":"Ann. Oncol."},{"key":"2021111915573589700_BST-2019-0707CC70","doi-asserted-by":"publisher","first-page":"31141","DOI":"10.1074\/jbc.M504113200","article-title":"DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras","volume":"280","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC71","doi-asserted-by":"publisher","first-page":"41268","DOI":"10.1074\/jbc.M206573200","article-title":"Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae","volume":"277","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC72","doi-asserted-by":"publisher","first-page":"49352","DOI":"10.1074\/jbc.M209760200","article-title":"Erf4p and Erf2p form an endoplasmic reticulum-associated complex involved in the plasma membrane localization of yeast Ras proteins","volume":"277","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC73","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1021\/bi00011a039","article-title":"Doubly-lipid-modified protein sequence motifs exhibit long-lived anchorage to lipid bilayer membranes","volume":"34","year":"1995","journal-title":"Biochemistry"},{"key":"2021111915573589700_BST-2019-0707CC74","doi-asserted-by":"publisher","first-page":"13102","DOI":"10.1021\/bi9709497","article-title":"S-Acylation and plasma membrane targeting of the farnesylated carboxyl terminal peptide of N-ras in mammalian fibroblasts","volume":"36","year":"1997","journal-title":"Biochemistry"},{"key":"2021111915573589700_BST-2019-0707CC75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20121799","article-title":"Ras palmitoylation is necessary for N-RAS activation and signal propagation in growth factor signalling","volume":"454","year":"2013","journal-title":"Biochem. J."},{"key":"2021111915573589700_BST-2019-0707CC76","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1182\/blood-2009-03-213876","article-title":"Palmitoylation of oncogenic N-RAS is essential for leukemogenesis","volume":"115","year":"2010","journal-title":"Blood"},{"key":"2021111915573589700_BST-2019-0707CC77","doi-asserted-by":"publisher","first-page":"17898","DOI":"10.1073\/pnas.1317528110","article-title":"MicroRNA-134 activity in somatostatin interneurons regulates H-Ras localisation by repressing the palmitoylation enzyme DHHC9","volume":"110","year":"2013","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC78","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1086\/513609","article-title":"Mutations in zDHHC9, which encodes a palmitoyltransferase of N-Ras and H-Ras, cause X-linked mental retardation associated with a marfanoid habitus","volume":"80","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"2021111915573589700_BST-2019-0707CC79","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ajmg.a.36348","article-title":"Expanding the clinical phenotype of patients with a zDHHC9 mutation","volume":"164","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"2021111915573589700_BST-2019-0707CC80","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/acn3.196","article-title":"Epilepsy, cognitive defects and neuroanatomy in males with zDHHC9 mutations","volume":"2","year":"2015","journal-title":"Ann. Clin. Trans. Neurol."},{"key":"2021111915573589700_BST-2019-0707CC81","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/ejhg.2015.5","article-title":"Next-generation sequencing in X-linked intellectual disability","volume":"23","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"2021111915573589700_BST-2019-0707CC82","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.celrep.2019.10.065","article-title":"The X-Linked intellectual disability gene Zdhhc9 is essential for dendrite outgrowth and inhibitory synapse formation","volume":"29","year":"2019","journal-title":"Cell Rep."},{"key":"2021111915573589700_BST-2019-0707CC83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/341209a0","article-title":"Structure of the guanine-nucleotide-binding domain of the H-ras oncogene product p21 in the triphosphate conformation","volume":"341","year":"1989","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC84","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1073\/pnas.1116510109","article-title":"Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity","volume":"109","year":"2012","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC85","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1002\/anie.201201358","article-title":"Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation","volume":"51","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2021111915573589700_BST-2019-0707CC86","doi-asserted-by":"publisher","first-page":"8182","DOI":"10.1073\/pnas.1217730110","article-title":"In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction","volume":"110","year":"2013","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC87","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cell.2017.02.006","article-title":"Multivalent small-molecule pan-RAS inhibitors","volume":"168","year":"2017","journal-title":"Cell"},{"key":"2021111915573589700_BST-2019-0707CC88","doi-asserted-by":"publisher","first-page":"15823","DOI":"10.1073\/pnas.1904529116","article-title":"Drugging an undruggable pocket on KRAS","volume":"116","year":"2019","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC89","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nchembio.612","article-title":"An orthosteric inhibitor of the Ras-Sos interaction","volume":"7","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"2021111915573589700_BST-2019-0707CC90","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1021\/acsmedchemlett.7b00128","article-title":"Crystal structure of a human K-Ras G12D mutant in complex with GDP and the cyclic inhibitory peptide KRpep-2d","volume":"8","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"2021111915573589700_BST-2019-0707CC91","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1194\/jlr.M700179-JLR200","article-title":"Cellular palmitoylation and trafficking of lipidated peptides","volume":"48","year":"2007","journal-title":"J. Lipid Res."},{"key":"2021111915573589700_BST-2019-0707CC92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1242\/jcs.020107","article-title":"Palmitoylation and localisation of RAS isoforms are modulated by the hypervariable linker domain","volume":"121","year":"2008","journal-title":"J. Cell Sci."},{"key":"2021111915573589700_BST-2019-0707CC93","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0092-8674(90)90294-O","article-title":"A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane","volume":"63","year":"1990","journal-title":"Cell"},{"key":"2021111915573589700_BST-2019-0707CC94","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1073\/pnas.1412811112","article-title":"K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif","volume":"112","year":"2015","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111915573589700_BST-2019-0707CC95","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature05098","article-title":"Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning","volume":"443","year":"2006","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC96","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1093\/hmg\/ddm191","article-title":"Humanized MC1R transgenic mice reveal human specific receptor function","volume":"16","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021111915573589700_BST-2019-0707CC97","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1074\/jbc.M406334200","article-title":"\u03b1-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage","volume":"280","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021111915573589700_BST-2019-0707CC98","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1158\/0008-5472.CAN-04-4535","article-title":"\u03b1-melanocortin and endothelin-1 activate anti-apoptotic pathways and reduce DNA damage in human melanocytes","volume":"65","year":"2005","journal-title":"Cancer Res."},{"key":"2021111915573589700_BST-2019-0707CC99","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/302711","article-title":"Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?","volume":"66","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"2021111915573589700_BST-2019-0707CC100","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/hmg\/10.21.2397","article-title":"Functional variation of MC1R alleles from red-haired individuals","volume":"10","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"2021111915573589700_BST-2019-0707CC101","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/ijc.23396","article-title":"MC1R variants, melanoma and red hair color phenotype: a meta-analysis","volume":"122","year":"2008","journal-title":"Int. J. Cancer"},{"key":"2021111915573589700_BST-2019-0707CC102","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/ijc.25804","article-title":"Melanocortin-1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden","volume":"129","year":"2011","journal-title":"Int. J. Cancer"},{"key":"2021111915573589700_BST-2019-0707CC103","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1038\/ncomms12064","article-title":"Germline MC1R status influences somatic mutation burden in melanoma","volume":"7","year":"2016","journal-title":"Nat. Commun."},{"key":"2021111915573589700_BST-2019-0707CC104","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature23887","article-title":"Palmitoylation-dependent activation of MC1R prevents melanomagenesis","volume":"549","year":"2017","journal-title":"Nature"},{"key":"2021111915573589700_BST-2019-0707CC105","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm2450","article-title":"ATR: an essential regulator of genome integrity","volume":"9","year":"2008","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"2021111915573589700_BST-2019-0707CC106","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-019-08691-3","article-title":"Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"key":"2021111915573589700_BST-2019-0707CC107","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.1021\/ja303400u","article-title":"Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes","volume":"134","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"2021111915573589700_BST-2019-0707CC108","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1039\/C3MD00333G","article-title":"Acyl protein thioesterase inhibitors as probes of dynamic S-palmitoylation","volume":"5","year":"2014","journal-title":"Medchemcomm"},{"key":"2021111915573589700_BST-2019-0707CC109","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1021\/acschembio.6b00720","article-title":"Molecular mechanism for isoform-selective inhibition of acyl protein thioesterases 1 and 2 (APT1 and APT2)","volume":"11","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"2021111915573589700_BST-2019-0707CC110","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","year":"2012","journal-title":"Nature Rev. Cancer"},{"key":"2021111915573589700_BST-2019-0707CC111","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/pros.21020","article-title":"Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+","volume":"69","year":"2009","journal-title":"Prostate"},{"key":"2021111915573589700_BST-2019-0707CC112","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumour antigen-specific CD8T cells infiltrating the tumour express high levels of PD-1 and are functionally impaired","volume":"114","year":"2009","journal-title":"Blood"},{"key":"2021111915573589700_BST-2019-0707CC113","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","year":"2002","journal-title":"Nat. Med."},{"key":"2021111915573589700_BST-2019-0707CC114","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 Blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2021111915573589700_BST-2019-0707CC115","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced non-squamous non-small-cell lung cancer","volume":"373","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2021111915573589700_BST-2019-0707CC116","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2021111915573589700_BST-2019-0707CC117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2021111915573589700_BST-2019-0707CC118","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41389-017-0013-7","article-title":"Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy","volume":"7","year":"2018","journal-title":"Oncogenesis"},{"key":"2021111915573589700_BST-2019-0707CC119","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41551-019-0383-6","article-title":"Tumour suppression by blocking palmitoylation","volume":"3","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"2021111915573589700_BST-2019-0707CC120","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","article-title":"Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","volume":"3","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"2021111915573589700_BST-2019-0707CC121","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd.2018.21","article-title":"Kinase inhibitors: the road ahead","volume":"17","year":"2018","journal-title":"Nature Rev. Drug Discov."},{"key":"2021111915573589700_BST-2019-0707CC122","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nchembio.362","article-title":"Small-molecule inhibition of APT1 affects Ras localization and signalling","volume":"6","year":"2010","journal-title":"Nature Chem. Biol."},{"key":"2021111915573589700_BST-2019-0707CC123","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1158\/1535-7163.MCT-06-0114","article-title":"Discovery and characterization of inhibitors of human palmitoyl acyltransferases","volume":"5","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"2021111915573589700_BST-2019-0707CC124","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/09687680802683839","article-title":"Palmitoyl acyltransferase assays and inhibitors","volume":"26","year":"2009","journal-title":"Mol. Memb. Biol."},{"key":"2021111915573589700_BST-2019-0707CC125","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09687680802646703","article-title":"Palmitoyl acyltransferases, their substrates, and novel assays to connect them","volume":"26","year":"2009","journal-title":"Mol. Memb. Biol."},{"key":"2021111915573589700_BST-2019-0707CC126","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1517\/17460440903548218","article-title":"Identification of targets and inhibitors of protein palmitoylation","volume":"5","year":"2010","journal-title":"Expert. Opin. Drug Discov."},{"key":"2021111915573589700_BST-2019-0707CC127","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1517\/17460441.2014.933802","article-title":"Targeting protein palmitoylation: selective inhibitors and implications in disease","volume":"9","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"key":"2021111915573589700_BST-2019-0707CC128","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00232-015-9835-4","article-title":"Pharmacological inhibition of protein lipidation","volume":"248","year":"2015","journal-title":"J. Membr. Biol."},{"key":"2021111915573589700_BST-2019-0707CC129","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/1386207319666160324123844","article-title":"Identification of protein palmitoylation inhibitors from a scaffold ranking library","volume":"19","year":"2016","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"2021111915573589700_BST-2019-0707CC130","doi-asserted-by":"publisher","first-page":"41147","DOI":"10.1038\/srep41147","article-title":"Click-chemistry based high throughput screening platform for modulators of Ras palmitoylation","volume":"7","year":"2017","journal-title":"Sci. Rep."},{"key":"2021111915573589700_BST-2019-0707CC131","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1038\/s41598-019-39968-8","article-title":"Identification of novel inhibitors of DLK palmitoylation and signaling by high content screening","volume":"9","year":"2019","journal-title":"Sci Rep"}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/48\/1\/281\/868641\/bst-2019-0707c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/48\/1\/281\/868641\/bst-2019-0707c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T16:10:26Z","timestamp":1637338226000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/48\/1\/281\/221690\/Therapeutic-targeting-of-protein-S-acylation-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,24]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12,24]]},"published-print":{"date-parts":[[2020,2,28]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20190707","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,24]]}}}